Wells Fargo
ARRY

Wells Fargo’s Array Biopharma Inc ARRY Stock Holding History

Wells Fargo’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-99,200
Closed -$42K – 6656
2017
Q3 		$42K Buy
+99,200
New +$921K ﹤0.01% 5529

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Wells Fargo's ARRY Position: Q3 2019 in Review

Wells Fargo sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 251,110 shares — an estimated $11.6M sold.

Wells Fargo first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $50.6M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Wells Fargo reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Wells Fargo sold 251,110 Array Biopharma Inc shares in Q3 2019, an estimated $11.6M.
  • Wells Fargo first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
  • Wells Fargo's Array Biopharma Inc position peaked at $50.6M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Wells Fargo's 13F filing for Q3 2019, filed 12 Nov 2019.